Bcl-2 family proteins are involved in the cell homeostasis by regulating programmed cell death. Some of these proteins promote apoptosis, while others inhibit the same process. The C-terminal hydrophobic domain of some of these proteins is predicted to be involved in anchoring them to a variety of cell membranes, such as mitochondrial, endoplasmic reticulum and nuclear membranes. We have used five synthetic peptides imitating the C-terminal domain from both anti-apoptotic (Bcl-2) and pro-apoptotic members (Bak, Bax, and two mutants of this last protein) of this family to study their interaction with model membranes. Some differences were detected in the interaction with these peptides. The addition of all the peptides to large unilamellar vesicles destabilized them and released encapsulated carboxyfluorescein to different degrees, so that fluidity and the increase in negative curvature favoured the extent in the release of carboxyfluorescein. Bcl-2-C and Bax-C peptides produced the highest release levels in most cases, while BaxS184K-C was the least efficient in this respect. These results indicate that these C-terminal domains are able to insert themselves in the membranes, each in a different way that is probably related with their different way which can be related to their differing locations within the cell and their different roles in regulating apoptosis.
Introduction
Programmed cell death (apoptosis) controls normal tissue homeostasis by balancing cell proliferation and removing damaged, unwanted, aged and infected cells [1] [2] [3] . Alteration of the normal apoptotic process is symptomatic of several human diseases [4, 5] . Due to its vital importance, apoptosis is a highly regulated mechanism, the proteins of the Bcl-2 family being one of the most important factors involved in such regulation since they are responsible for integrating diverse survival and death signals that are generated outside and inside the cell [6, 7] . These proteins can form homo-and heterodimers [8] [9] [10] .
The multi-BH domain family members are either anti-or proapoptotic proteins. In general, the anti-apoptotic members (e.g., Bcl-2, Bcl-x L , Mcl-1, Bcl-w from mammals and Ced-9 from Caenorhabditis elegans) display sequence homology in all four BH domains, whereas the pro-apoptotic members (e.g., Bax, Bak and Bok) have homologous BH1-3 domains. Pro-apoptotic Bcl-2 family members, upon activation by apoptotic stimuli, are capable of forming heterodimers with anti-apoptotic members. The solution structure of Bcl-x L reveals that the BH1-3 domains of Bcl-x L form an elongated hydrophobic groove, which is the docking site for the BH3 domains of pro-apoptotic binding partners [11] [12] .
In addition to BH domains, many of these proteins contain a hydrophobic transmembrane domain (TMD) at their carboxy terminus. This C-terminal domain is supposedly responsible for membrane localization, for example, in the outer membrane of mitochondria, the nucleus or in the endoplasmic reticulum membranes [13] [14] [15] [16] [17] [18] , indicating that these proteins may exist as integral membrane proteins [19] [20] [21] . The pattern of membrane localization differs among pro-and anti-apoptotic members. In this sense, Bcl-2 has been shown to reside on the cytoplasmic face of the mitochondrial outer membrane, whereas Bax or Bid is found mainly in the cytosol or as membrane peripherals in healthy living cells, and only interacts with the mitochondrial membrane when they are activated [22] [23] [24] [25] .
Some of the Bcl-2 family members have been cloned and expressed for studies at high resolution. However, many of these studies used truncated forms which do not include the hydrophobic C-terminal domain in order to obtain the high quantities of soluble protein required for the structural studies, because full proteins are of impaired solubility. Nevertheless, the structures of a few full-length proteins have been determined, and in all cases, the C-terminal segments were shown to fold back onto a groove on the structures, similarly to Bax [26] .
Homeostasis is maintained by controlling the amount of active pro-and anti-apoptotic family members in different tissues. The ratio between pro-and anti-apoptotic proteins helps to determine, in part, the susceptibility of cells to a death signal and, when called for, programmed cell death. These apoptotic signals target various intracellular components, including the pro-apoptotic Bcl-2 members.
The hydrophobic C-terminal domain is, it is supposed, very important in targeting these proteins to differing cell membranes, as mentioned above. In this sense, a comparative study of different C-terminal domains of pro-and anti-apoptotic Bcl-2 proteins would be very interesting to help elucidate the role of each one. In the present study, we have used five synthetic peptides imitating the C-terminal domain of some of the Bcl-2 family proteins, namely Bcl-2-C, Bak-C, Bax-C and two mutants of this last protein (Fig. 1 ), and studied their interaction with different model membranes and their ability to disrupt membrane barrier properties using fluorescence spectroscopy. The results showed that the interaction of each peptide with the model membranes, as seen through the release of encapsulated carboxyfluorescein, differed, with Bcl-2-C and BaxS184K-C showing the weakest effects.
Materials and methods

Materials
The synthetic Bcl-2 C-terminal domain peptide (Bcl-2-C) encompassed residues 217-239 of Bcl-2 ( + 3 HN-217 LTKLLSLALVGACITLGAYLGHK 239 -COO − ), whereas the synthetic Bak C-terminal domain peptide (Bak-C) included residues 188-211 of Bak ( + 3 HN-188 ILNVLVVLGVVLLGQFVVRRFFKS 211 -COO − ). The three remaining synthetic peptides were related, because one, the Bax C-terminal domain peptide (Bax-C), encompassed residues 172-192 of Bax ( + 3 HN-172 TVTIFVAGVLTASLTIWKKMG 192 -COO − ) and the other two were mutants of the previous one, so that Ser184 was replaced by Lys184 (Bax S184K-C) and in the second Ser184 was deleted (BaxΔS184-C). The five synthetic peptides were purchased from Genemed (San Francisco, CA, USA) and judged pure (N95%) according to the quality control by HPLC and MALDI-TOF spectroscopy carried out by the manufacturer.
Egg yolk phosphatidylcholine (EYPC), cholesterol (Chol) and egg yolk sphingomyelin (SM) were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL, USA). Egg yolk diacylglycerol (DAG) was prepared from egg yolk phosphatidylcholine by the action of phospholipase C (Bacillus cereus, Sigma Chemicals Co., Madrid, Spain) as previously described [27] . 11,6-Diphenyl-1,3,5-hexatriene (DPH), 2,2,2-trifluoroethanol (TFE), and Triton X-100 were obtained from Sigma Chemicals Co. (Madrid, Spain). 5(6)-Carboxyfluorescein (CF) was obtained from Kodak (Eastman Kodak Co., Rochester, NY, USA). The other solvents were from Merck (Darmstadt, Germany) and all other reagents used in this work were of analytical grade. Water was twice distilled and deionized using a Millipore system from Millipore Ibérica (Madrid, Spain). All fluorescence experiments were performed using a Fluoromax-3 fluorescence spectrophotometer (Jobin Yvon, Longjumeau, France).
Preparation of lipid mixtures for the leakage experiments
Lipid vesicles were generated by mixing chloroform solutions of the different lipids at the desired molar proportions. Lipid mixtures were dried under a stream of oxygen-free nitrogen, and then the last traces of organic solvents were removed by a further 3-h evaporation under high vacuum. Dried lipids were resuspended in the corresponding buffers by vigorous vortexing in the liquidcrystalline phase, i.e., above the transition temperature of the lipid mixture, to produce multilamellar vesicles (MLVs). These vesicles were used in the fluorescence polarization experiments.
In the case of fluorescence carboxyfluorescein leakage, large unilamellar vesicles (LUVs) were used. These were prepared using the extrusion technique [28, 29] . Briefly, MLVs were frozen and thawed at 30°C (temperature above the transition temperature of the lipid mixtures) five times and then the suspensions were extruded 10 times through two stacked 100-nm polycarbonate filters (Millipore Inc., Bedford, USA).
The quantification of the lipids was carried out in according to Böttcher et al. [30] .
Leakage of liposome contents
Leakage of the liposome content to the external medium was kinetically monitored by measuring the release of the 5(6)-carboxyfluorescein (CF) trapped inside the vesicles [31] [32] [33] [34] . The fluorescence dye (CF) was purified by gel filtration on a Sephadex LH-20 (1 × 30) column in 10 mM HEPES pH 7.4 buffer and stored at 4°C in the dark.
Lipid mixtures were hydrated in a 50-mM Mes pH 7.4, 50 mM K 2 SO 4 buffer, containing 50 mM purified CF [32] . LUVs were prepared and purified as previously described [35] .
The increase in CF fluorescence upon CF release was followed using an excitation wavelength of 492 nm (5-nm slit width) and monitoring the emission intensity at 520 nm (10-nm slit width). Measurements were made in a thermostated quartz cuvette with constant stirring at 25°C. Each sample contained 10 μM LUVs in 2 ml of 50 mM Mes pH 7.4, 100 mM K 2 SO 4 buffer. A baseline measurement of the fluorescence of the vesicles alone was made for 15 min. In our experimental conditions the spontaneous leakage rate was b5%. Then the different peptides were dissolved in TFE at 2 or 0.5 mg/ml and added to the solution. Different volumes of TFE alone were also added to check the leakage produced by this organic solvent. The addition of up to 4 μl of TFE did not produce any substantial additional leakage. After adding of the peptides, fluorescence was monitored for 15 min, and then a small volume of concentrated Triton X-100 (final concentration 0.5%, w/v) was added to determine the maximum fluorescence attainable under conditions of totally solubilized vesicles. The percentage of CF released was determined by the following equation:
where F t=15 min is the maximum fluorescence intensity 15 min after the addition of the peptide or TFE, F 0 is the fluorescence intensity of vesicles alone at time 0, and F max is the fluorescence intensity after the addition of Triton X-100.
Binding of peptides to lipid vesicles
Samples were prepared from lipid stocks dissolved in chloroform and peptide stocks dissolved in 2,2,2-trifluoroethanol (TFE). A total of 100 μg of peptides and the appropriate quantity of lipids to obtain a molar peptide-lipid ratio of 0.02 were dried under a stream of nitrogen. The last traces of solvent were removed by evaporation under high vacuum for at least 2 h. Then 200 μl of TFE was added and the samples were vortexed and dried again in the same way as previously described. Samples were hydrated in 400 μl of buffer containing 50 mM MES, 50 mM K 2 SO 4 pH 7.4. Once formed, vesicles were centrifuged and the liposome phase at the top and the supernatant was separated from the precipitated peptides [36] . The phospholipid phase and the supernatant were centrifuged again in the same conditions and finally the supernatant was removed with a syringe. Samples were dissolved in 400 μl of TFE/formic acid (99.5:0.5) and injected into the HPLC/MS system.
The quantification analysis was carried out on an HPLC/MS system consisting of an Agilent 1100 Series HPLC (Agilent Technologies, Santa Clara, CA, USA) equipped with a quaternary pump, a thermostated μ-wellplate autosampler, and a DAD module connected to an Agilent Ion Trap XCT Plus Mass Spectrometer (Agilent Technologies, Santa Clara, CA, USA) using an electrospray (ESI) interface.
Samples and standards with known concentrations of each peptide were prepared by dissolving 100 μg each peptide in 400 μl of TFE/formic acid (99.5:0.5) and injected into a Supelco Discovery C18 HPLC column (5 μm, 100 × 2.1 mm, Supelco, Pennsylvania, USA). The column was thermostated at 40°C, and the peptides were eluted at a flow rate of 0.1 ml/min. Mobile phase A (99.5:0.5, water/formic acid) and mobile phase B (99.5:0.5 methanol/formic acid) were used for the chromatographic separation. The elution consisted of 5 min of 10% B, and a linear gradient from 10 to 100% B in 10 min. 100% B was maintained for 10 min. The column was equilibrated with the starting composition of the mobile phase (10% B) for 20 min before each analytical run. The UV signal at 280 nm was recorded. The mass spectrometer was operated in the positive mode with a capillary spray voltage of 3500 V and a scan speed of 26,000 (m/z)/s from 200-3200 m/z. The nebulizer gas (He) pressure was set to 30 psi, whereas the drying gas was set to a flow of 8 l/min at a temperature of 350°C.
The peptides were quantified using both the UV and the extracted ion chromatogram of the most intense peptide ion. Calibration curves were calculated with known standard concentrations of each peptide. The peak area of both UV and extracted ion chromatogram was quantified using the DataAnalysis program for LC/MSD Trap Version 3.2 (Bruker Daltonik, GmbH, Germany). Similar results were obtained when using the UV and the mass spectroscopy detectors. The results shown are those from the mass spectrometry.
Laser light scattering measurements
LUVs' size was measured by means of a Malvern Autosizer 4800 Spectrometer (240 V) equipped with a RR98 pump/filter unit. Samples were measured at a temperature of 25°C and at a wavelength of 488 nm. The scattering angle was set at 90°and the proportions of the solvent were refractive index 1.33 and viscosity 0.95 cP. The vesicle sizes were recorded in the absence and in the presence of each peptide, which when present gave a peptide-lipid molar ratio of 0.02.
Fluorescence polarization
MLVs including the fluorescent probe 1,6-diphenyl-1,3,5-hexatriene (DPH) at a lipid/probe molar ratio of 500:1 were prepared in 10 mM HEPES pH 7.4, 0.1 mM EDTA filtered buffer as previously described [35] . Three independent samples including 20 nmol of total lipid of each mixture were analyzed.
DPH fluorescence polarization was measured using excitation and emission wavelengths of 350 and 452 nm, respectively, with a slit width of 5 nm for both excitation and emission. Fluorescence polarization was measured at a constant temperature of 25°C with continuous stirring inside the cuvette in order to prevent the settling of the vesicles. In the fluorescence polarization experiment, the sample was excited with a polarized beam, and the components of the emission parallel or perpendicular to the direction of the excitation beam were measured. The polarization of the emitted fluorescence, P, was determined as
where a correction factor for the instrumental response of the two components of emission has been applied [37] . I 90,0 is the fluorescence intensity when the excitation polarizer is perpendicular to the direction of the beam and the emission is parallel; I 90,90 and I 0,0 , when both are perpendicular or parallel, respectively; and I 0,90 , when the excitation polarizer is parallel while the emission polarizer is perpendicular to the direction of the beam. To ensure that there was no polarization due to light scattering, polarization was measured before and after sample dilution. In cases when dilution led to an increased level of P, the samples were diluted until the value of P remained constant.
Results
Ability of the C-domains to incorporate into membranes
It is interesting to compare the different C-domains with respect to their capacity to incorporate into membranes containing different lipids. This was analyzed after the addition of peptides to preformed vesicles and centrifugation of the vesicles and flotation in 2 H 2 O buffer, at a peptide to lipid molar ratio of 0.02 [36] . Table 1 shows that in the case of Bak-C the level of peptide incorporation was quite similar for EYPC, EYPC plus 10 mol% of POG and in the presence of 10 mol% of cyclosporin A. Incorporation was greater, however, after the addition of cholesterol, while it decreased slightly after the addition of SM.
In the case of Bax-C, very similar levels of incorporation were observed for EYPC alone and in the presence of cyclosporin A. A reduced level was detected in the case of POG, cholesterol and particularly in the case of SM.
As regards BaxΔS184-C, peptide incorporation was slightly higher after the addition of POG and SM than in the presence of pure EYPC, with cholesterol and cyclosporin A permitting higher increases.
In contrast, when BaxS184K-C was studied, the addition of other membrane components to EYPC led to a decrease in incorporation in all cases, particularly in the case of SM.
Finally, when Bcl-2-C was studied, the only addition which significantly modified the level of incorporation was cyclosporin A, which led to a substantial increase.
Effect of incorporating C-terminal domains on the sizes of lipid vesicles
The interaction of the C-terminal domains with the different membranes may have as a consequence their macroscopic change due to fusion or important morphologic rearrangements. These changes can be monitored by laser light scattering which reports on the size distribution of the vesicles. Table 2 shows that the size of the vesicles was very similar in all cases and was not greatly modified by the addition of the peptides. Variations in size did not exceed 15% in any case, and therefore no substantial changes in morphology were detected.
6-Carboxyfluorescein leakage induced by C-terminal domain peptides from Bcl-2 family of proteins
To assess the interaction of the peptides in the LUV model membranes used in this study, the release of encapsulated 5(6)carboxyfluorescein (CF) trapped inside the vesicles was monitored at 25°C. The time course of a typical experiment with egg yolk PC LUV and Bak-C peptide is shown in Fig. 2 . It can be seen that dye leakage started very soon after peptide addition, The values were multiplied by a factor of 10 3 . Three independent experiments were carried out. and most of the dye had already been released after 15 min; this time was therefore taken as a reference for comparing the effect of the different peptides. Triton X-100 was added at the end of the experiment to release the rest of CF.
In the following experiments, CF release was measured with increasing concentrations of each peptide. The percentage of CF released 15 min after the addition of each peptide concentration is depicted in Figs. 3 and 4 . Table 3 shows the percentage of CF released at a peptide-lipid molar ratio of 0.02. Nevertheless, the results have been corrected according to the actual quantities of peptides incorporated and expressed in percent of CF released by 0.1 ng of peptide. The results showed that, with respect to pure EYPC, only DAG increased the rate of dye release, with all the peptides. It can be seen that, although Figs. 3 and 4 show values of release which are not corrected for the actual quantity of peptide incorporated into the vesicles, qualitatively the results are the same than after correcting for this incorporation, as seen in Table 3 .
The addition of the C-terminal domain peptide from Bcl-2 and Bak ( Fig. 3 ) and from Bax, BaxΔS184 and BaxS184K (Fig. 4) had different effects, depending on the type of vesicles used. In the case of Bak-C (Fig. 3A) , only the addition of DAG (EYPC/DAG, 9:1 molar ratio) produced an increase in the percentage of CF release with respect to pure EYPC vesicles. In this way, whereas in the case of EYPC vesicles the release was 31.8%, this increased to 37.2% in the presence of DAG. All the other additions caused a reduction in the release, with 20.3%, 27.4% and 13.6% produced by the addition of cholesterol (EYPC/chol, 4:1 molar ratio), sphingomyelin (EYPC/SM, 4:1 molar ratio) and cyclosporin A (EYPC/cyclosporin A, 9:1 molar ratio), respectively, to the EYPC vesicles.
Qualitatively similar results were obtained for the other four peptides ( Table 3 and Figs. 3 and 4) , with DAG increasing the amount of dye release and the other three additives decreasing this release. The minimum release values were observed for cyclosporin A with all five peptides, values as low as 13.6%, 9.9%, 12.2% 8.4% and 10.3% being obtained for Bak-C, Bax-C, BaxΔS184-C, BaxS184K-C and Bcl-2-C, respectively.
When the five peptides added to pure EYPC vesicles were compared (Table 3) , it was observed that the maximum release was obtained for Bcl-2-C (44.1%) and Bax-C (36.4%), while the minimum release corresponded to BaxS184K-C (23.0%). Qualitatively similar results were obtained when comparing the peptides added to the other four types of membrane.
Fluorescence polarization of diphenyl hexatriene
The steady-state polarization value (P) provides a timeaveraged indication of the mobility of a fluorophore. DPH is a hydrophobic fluorescent molecule which, when incorporated into a lipid bilayer, is located in the hydrophobic region. When a lipid mixture is above its transition temperature, i.e., in the fluid phase, DPH is freely mobile, and its fluorescence is minimally polarized. This probe has been widely used to study the effect of proteins on membrane order [38] . Higher values of polarization show a decrease in the mobility of the probe. In order to assess the possible origin of the different effects produced by each peptide on the membranes, the steady-state polarization (P) of each lipid mixture was measured at 25°C.
The results showed that whereas P was 0.183 ± 0.015 (three different experiments), the addition of DAG (EYPC/DAG, 9:1 molar ratio) did not significantly modify this value (0.182 ± 0.012). However, there were significant increases in P after the other three additions: 0.223 ± 0.008 for EYPC/Chol (4:1 molar ratio), 0.210 ± 0.016 for EYPC/SM (4:1 molar ratio) and 0.238 ± 0.013 for EYPC/cyclosporin A (9:1 molar ratio). These data suggest that the differing effects of the peptides on the stability of the membranes used here are related with the difference between their respective fluidities.
Discussion
Taking into account that the CF released was different for each peptide with each lipid mixture, these data as a whole suggest that the most affected membrane contained EYPC/DAG, while the membrane including cholesterol was the least affected, i.e., the most stable in the presence of the peptides. On the other hand, when all the peptides are compared, the data suggest that Bcl-2-C and Bax-C permitted the highest CF release values, while BaxS184K-C was the least efficient in this respect. This may be related with the differing capacity to span the membrane of these domains. It has been shown before [39] that the substitution S184K produces a Bax-C form with a charged amino acyl chain located in the middle of the hydrophobic stretch and hence its capacity to span the membrane is greatly reduced. The present results indicate that the peptides may differentially disrupt the barrier properties of the phospholipid bilayer as a function of their ability to span the membrane. Bax has been shown to form multispanning monomers that oligomerize to permeabilize membranes during apoptosis and inserts into the membrane through the pore domain (helices α5-α6) and also the C-domain (helix α9) [40] . The in vivo importance of residue S184 to determine mitochondrial localization of Bax has been shown before, when mutation S184K led to a diffuse cytoplasmic localization of Bax [41] .
In the case of Bcl-2-C [35] and Bak-C [42] , it has previously been shown that they form α-helices with an orientation nearly perpendicular to the plane of the membrane in the case of membranes of reduced thickness (like DMPC) but form random structures which do not span the membrane when the thickness is greater [43] . In fact, the membranes used in this work are thick enough to avoid the formation of spanning α-helices by both Bcl-2-C and Bak-C. Therefore, small changes in the membrane properties are essential for determining whether they will or not be able to destabilize the barrier properties of the bilayer. It should be remarked that Bak-C shows a higher destabilizing capacity than Bcl-2-C in most of the membranes studied, as measured by the release of CF, except in the presence of DAG, when both domains behaved similarly. The differences in the effects produced by the four additives tested can be explained by their capacity to modulate membrane structure. Due to the small size of its polar group, DAG produces several effects in the membrane (reviewed in [44] ), including enhancing the tendency of the membrane to adopt nonbilayer structures [45] , such as lipidic particles [44] , spacing the polar head groups of the phospholipids [46] and dehydration of the membrane surface [47] . All these effects facilitate the insertion of proteins in the membrane and will therefore enhance the destabilization of the lipid bilayer, which is necessary for dye release. Cholesterol modulates membrane fluidity [48] and, when added to a fluid membrane like that of EYPC, will decrease this fluidity and increase membrane stability, as is shown by our fluorescence probe polarization measurements. Hence the presence of cholesterol is expected to decrease the capacity of the peptides to induce CF release. The sphingomyelin used here has a high percentage of saturated ester acyl chains (80% of palmitic) and so it, too, decreases membrane fluidity, as was also shown by our fluorescence polarization measurements. Finally, cyclosporin A is known to produce positive curvature in the membrane [49] and therefore has an opposite effect to DAG, hindering peptide insertion of the peptides in the membrane. Additionally, fluorescence polarization shows that cyclosporin A has the additional effect of reducing membrane fluidity, which would explain its drastic effect on CF release.
The insertion of other proteins in the membrane has been shown to be regulated by membrane curvature and/or fluidity, as is the case with cytochrome b 5 [50] , ArfGAP1 [51] , PI-specific phospholipase C [52] and aerolysin [53] , among many others, and also by specific interactions with some phospholipids such as protein kinase C [54, 55] . It has also been suggested that Baxtype proteins change the bending propensity of the membrane to form pores comprised, at least partially, of lipids in a structure of net positive monolayer curvature [36] . This suggestion was made when using the full proteins and is clearly not the same mechanism at that operating for the C-terminal domains. Our results suggest, rather, that these peptides insert themselves in the membrane, forming a pore, and that DAG (which increases negative curvature) favours this process, whereas cyclosporin A, which increases positive curvature, and cholesterol, SM and the same cyclosporin A which decrease fluidity, hinder the insertion in the membrane of the peptides in the membrane and hence decrease the release of vesicle contents.
Studies with natural cytotoxic peptides [56] and with some synthetic peptides of amphipathic nature (see for example GALA [57] ) have revealed that they may facilitate the release of encapsulated carboxyfluorescein, because they self-associate within the membrane producing pores. Our results clearly show that the C-terminal domains of Bcl-2 proteins also have this capacity. It has been proposed that the C-terminal domain of pro-apoptotic Bax inserts itself in the membrane where, together with α5 and α6, it oligomerizes to produce pores [40] . In the case of other proteins like anti-apoptotic Bcl-2, it has been observed that it may form pores which are linked to the diffusion of ions such as H + through the mitochondrial membranes [58] . This protein lacking the C-terminal domain may also form channels in lipidic membranes [59, 60] . The whole Bcl-2 protein has not been used in this type of experiment with model membranes because of the difficulties involved in producing it in a soluble form. Nevertheless, by analogy with Bax [26] and Bcl-w [61] , it is tempting to predict that the C-terminal domain of Bcl-2 may also contribute to the formation of pores in biomembranes, and the same can be said with respect to Bak. Certainly the results obtained in this paper lend weight to this possibility.
According to our results, insertion of proteins of the Bcl-2 family into the membrane of the C-terminal domains may function as pores, a role that is regulated by the lipid composition and hence by changes occurring as a consequence of cell stimulation. Therefore, a given cell membrane may be more suitable than others for anchoring these proteins. This may have physiological significance when trying to explain the preference observed in vivo for a given cellular localization. It has recently been described that, at least in the endoplasmic reticulum of yeast, there is a receptor, independent of ATP hydrolysis, which may catalyze the incorporation into membranes of proteins containing a transmembrane C-terminal domain [62] . It remains to be seen whether such a receptor is also present in other organisms and in other organelles, as in mitochondria. Whatever the case is, interaction with lipids will always be a part of the translocation process, and this has been recognized in the case of cytochrome b 5 [50] . In the case of Bax, the 3D structure was determined for the full-length protein, and it was seen that the C-terminal segment folds back into a hydrophobic groove formed by the other BH domains [26] . When cell signalling targets Bax, a conformational change will displace the C-terminal domain from hydrophobic groove and the interaction of Bax proteins with membranes and with other proteins will now be possible. The interaction of the C-terminal domain with lipids may then stabilize this open and active conformation of Bax.
